Generic selectors
Exact matches only
Search in title
Search in content
Filter by Categories

Series B

ImmunoScape takes in $14m sight
UTEC has returned to co-lead a $14m funding round for ImmunoScape, which will use the money to bolster its presence in Singapore and the US.
Aphea.Bio harvests more series B capital
ECBF has supplied an extension to Aphea.Bio’s series B round, which already included Gemma Frisius Fund, Qbic, Vives and V-Bio Ventures.
Vizgen visualises $37m series B
Vizgen co-founder David Walt, a professor at Harvard Medical School, has invested in the spinout as part of its series B round.
Battery Resourcers charges up with $20m
Orbia Ventures led a round for the battery production technology provider that emerged out of Worcester Polytechnic Institute.
Snorkel AI pipes in $35m
GV returned for a series B round that increased the overall funding for Stanford’s machine learning technology developer to $50m.
Daily deal net: April 9, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Ventus Therapeutics executes $100m series B
RA Capital has led a $100m series B round for Ventus Therapeutics, which is linked to multiple universities.
Icosavax racks up $100m
RA Capital Management has led a series B round for the UW-linked vaccine developer, which had raised $51m in a series A 18 months ago.

Other News

Syzygy secures $23m series B
The Engine was among the returning investors for the Rice spinout’s series B round, having previously backed a series A in 2019.
Pyxis Oncology advances to $152m series B
The cancer treatment developer, co-founded by researchers from University of Chicago, has secured funding in a round co-led by Arix Bioscience and RTW Investments.
Immune-Onc gets $73m funding influx
The cancer therapy developer, which is commercialising research from University of Texas, has raised series B1 and B2 financing.
Daily deal net: March 31, 2021
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Entrada enters series B stage
Ohio State University spinout Entrada Therapeutics has pocketed $116m in a series B round.
Baraja bags $31m series B

Editor's Picks

Big deal: Ribon ties together $65m series B
Ribon Therapeutics has emerged out of stealth after three years of developing a lead asset targeting cancer based on research at MIT, UT Southwestern and Harvard Medical School.
Canvas paints $9m picture
Canvas Network, an online education platform developed by learning management software (LMS) provider Instructure which received $9.1m investment for the platform, has begun offering free and open online courses.
WRF finds its Resolve
In May 2010, Resolve raised $2m in the initial close of its A round before bringing in a corporate venturing unit later.
Imperial helps PsiOxus raise $34m
UK-listed investment fund Imperial Innovations joins GlaxoSmithKline's SR One, fund manager Invesco Perpetual and Lundbeckfond Ventures, backing the d cancer treatment company.
test reg